Rapt Therapeutics
(NASDAQ) RAPT
Rapt Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$105.64M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
RAPT News
RAPT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rapt Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
60
CEO
Brian Russell Wong, MD, PhD
Website
rapt.comHeadquarters
South San Francisco, CA 94080, US
RAPT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-62%
Return on Capital
-74%
Return on Assets
-64%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$136.10M
EBITDA
$134.90M
Operating Cash Flow
$83.30M
Capital Expenditure
$122.00K
Free Cash Flow
$83.42M
Cash & ST Invst.
$231.06M
Total Debt
$4.49M
Rapt Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
67
N/A
Net Income
$17.58M
+4.6%
EBITDA
$17.38M
+10.9%
Quarterly Fundamentals
Net Cash
$154.75M
+66.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$387.00K
-85.1%
Short Term Debt
$2.21M
-12.4%
Return on Assets
-63.74%
N/A
Return on Invested Capital
-73.93%
N/A
Free Cash Flow
$12.46M
+29.4%
Operating Cash Flow
$12.46M
+29.3%